Position in NVAX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$238,862
-$136,644 QoQ
Shares Held
25,357
-45.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 263 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,287,535 across 174 Biotechnology names. NVAX ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in NVAX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,862 | 25,357 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $375,506 | 46,131 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $347,491 | 51,710 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $417,703 | 48,178 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $336,659 | 53,438 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $388,458 | 60,602 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $570,743 | 70,988 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $618,074 | 48,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $463,444 | 36,607 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $177,830 | 37,203 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $137,438 | 28,633 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $152,213 | 21,024 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $151,950 | 20,451 | Shares | Sole | 2023-08-10 | |
| 2022-06-30 | $378,781 | 7,365 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $703,210 | 9,548 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,794,813 | 12,545 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,664,411 | 17,676 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,350,039 | 15,779 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,820,488 | 26,587 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,736,120 | 24,537 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $924,333 | 8,531 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $659,465 | 7,912 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||